Home > Cashflow Statement > AJANTA PHARMA

AJANTA PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

AJANTA PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-733 Cr₹-1,051 Cr₹-108 Cr₹-460 Cr₹-318 Cr

What is the latest Cash Flow from Financing Activities ratio of AJANTA PHARMA ?

The latest Cash Flow from Financing Activities ratio of AJANTA PHARMA is ₹-733 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-733 Cr
Mar2024₹-1,051 Cr
Mar2023₹-108 Cr
Mar2022₹-460 Cr
Mar2021₹-318 Cr

How is Cash Flow from Financing Activities of AJANTA PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-733 Cr
Negative
Mar2024 ₹-1,051 Cr
Negative
Mar2023 ₹-108 Cr
Negative
Mar2022 ₹-460 Cr
Negative
Mar2021 ₹-318 Cr -

Compare Cash Flow from Financing Activities of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹36,273.5 Cr -1.6% -1.9% 14.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,470.0 Cr -0.3% 3.1% 2.2% Stock Analytics
DIVIS LABORATORIES ₹161,996.0 Cr 0.5% -2.9% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,440.0 Cr 0.1% 1.4% 37.6% Stock Analytics
DR REDDYS LABORATORIES ₹108,417.0 Cr 1.9% 1.4% 10.7% Stock Analytics
CIPLA ₹101,445.0 Cr -3.3% -6.9% -17% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

-1.6%

-1.9%

14.4%

SENSEX

-0%

-10.7%

1%


You may also like the below Video Courses